Labclinics, S.A.

Labclinics, S.A. Echa un vistazo a nuestro blog www.labclinics.com/blog/ y ofertas en www.labclinics.com/ofertas/

Labclinics se constituyó en Barcelona en 1974, con el objeto de coordinar la comercialización y distribución de equipamiento y material de laboratorio para la investigación y el diagnóstico clínico en España y Portugal. Nuestro compromiso es ofrecer el mejor servicio a la comunidad científica y a la industria biotecnológica en la Península gracias a nuestro equipo comercial, servicio post venta y

a nuestra amplia gama de productos, que nos permite abastecer a múltiples áreas y disciplinas de la investigación biomédica y de la producción en biotecnología.

3x2 en kits de recogida de muestras para  . Nuestros kits contienen 1 escobillón nasofaríngeo y 1 vial con medio de tran...
14/04/2021

3x2 en kits de recogida de muestras para . Nuestros kits contienen 1 escobillón nasofaríngeo y 1 vial con medio de transporte inactivante del virus. Este medio inactiva la presencia del virus y preserva el RNA viral.
Más info: https://www.labclinics.com/ofertas-biologix/

Due to renal toxicity, 20% of compounds fail during clinical stages of drug development. Cell4Pharma developed   cells. ...
13/04/2021

Due to renal toxicity, 20% of compounds fail during clinical stages of drug development. Cell4Pharma developed cells. ciPTEC is a human renal cell line that mimics the proximal tubule cells of the kidney. These cells are a main target for drug-induced kidney injury, caused by their role in highly efficient transport of drugs and toxic compounds from the bloodstream into urine. The most relevant drug transporter proteins involved in this process are stably and functionally expressed in our cell models.

Join AstraZeneca Discovery Safety Specialist (Associate Principal Scientist) Dr. Anna-Karin Sjögren and Director for Safety Science and Discovery CVRM Dr. Mikael Persson as they discuss How to predict drug-induced nephrotoxicity during drug discovery.

Register here to join the discussion: https://lnkd.in/ev6yJzb

📢📢 PROMOCIÓN DE GeneTex, IncPide 2   de formato grande y obtén GRATIS un tercer anticuerpo de formato 25 μL. Echa un vis...
13/01/2021

📢📢 PROMOCIÓN DE GeneTex, Inc

Pide 2 de formato grande y obtén GRATIS un tercer anticuerpo de formato 25 μL. Echa un vistazo a los anticuerpos gratis incluidos.

Código promocional: GTX2+1

Promoción válida hasta el 31 de Marzo de 2021.

Más información en el siguiente enlace: https://www.labclinics.com/ofertas-genetex/

  (IF) is a   used to visualize a protein of interest in its cellular context. It is based on staining cells with   rais...
07/01/2021

(IF) is a used to visualize a protein of interest in its cellular context. It is based on staining cells with raised against a target protein that is directly conjugated with a fluorochrome or used together with fluorochrome-conjugated secondary antibodies. For answering to this experimental question in the most efficient manner, have a look to our blog entry about IF imaging: https://lnkd.in/ewXSCtr

Measure biomarkers of inflammation with ProcartaPlex     panels. Simultaneously quantitate up to 65 soluble immune bioma...
04/01/2021

Measure biomarkers of inflammation with ProcartaPlex panels. Simultaneously quantitate up to 65 soluble immune biomarkers from a single sample. Use preconfigured chemokine and cytokine panels or select from single targets to create your own custom panel to detect and quantitate the inflammatory response.

We invite you to read our blog entry. More information in the following link: https://lnkd.in/ekaMvU4

As public health demands increase, clinical laboratories seek robust, high-throughput, and low-cost technologies to addr...
13/08/2020

As public health demands increase, clinical laboratories seek robust, high-throughput, and low-cost technologies to address a crucial concern: accuracy. Learn how Agena Bioscience's five-assay based detection provides accurate results.
https://lnkd.in/gnaQ9Ck

07/08/2020

Quer estar informado sobre a eficácia dos medicamentos que está a utilizar? E evitar efeitos secundários, agora e no futuro?

A HeartGenetics tem o prazer de anunciar o lançamento no mercado português do teste genético MyPharmaGenes.

O objectivo? Fornecer uma ferramenta inovadora e única na Europa que permite a personalização da prescrição de medicamentos de forma mais segura, mais eficaz e com um melhor custo-benefício para o tratamento.
E porquê? Da mesma forma que cada doença é pessoal, também o seu tratamento o é.

O teste MyPharmaGenes:
💙 informa sobre a resposta do organismo a vários medicamentos em 5 áreas terapêuticas (Psiquiatria, Gestão da dor, Oncologia, Diabetes e Cardiovascular)
💙 é suportado por uma App que pode ser usada sempre que compra um medicamento

Tem interesse em realizar o teste?
1️⃣ O teste MyPharmaGenes poderá ser realizado no Laboratório Central (Lisboa) e no Laboratório do Porto do Grupo Germano de Sousa.
Ou,
2️⃣ Peça ao seu médico para entrar em contacto connosco.

Para mais informações, consulte a página https://www.heartgenetics.com/genetic-services/pharmacogenetics/mypharmagenes-pgx/

Dirección

Calle Industria 54
Barcelona
08025

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando Labclinics, S.A. publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.

Contacto El Consultorio

Enviar un mensaje a Labclinics, S.A.:

Compartir